Commission Regulation (EU) No 944/2013 of 2 October 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures Text with EEA relevance
944/2013 • 32013R0944
Legal Acts - Regulations
- 76 Inbound citations:
- •
- 2 Cited paragraphs:
- •
- 38 Outbound citations:
3.10.2013
EN
Official Journal of the European Union
L 261/5
COMMISSION REGULATION (EU) No 944/2013
of 2 October 2013
amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 37(5) and Article 53 thereof,
Whereas:
(1)
In respect of precautionary statement P210 set out in table 6.2 Part 1 of Annex IV to Regulation (EC) No 1272/2008 the 5th revision of the Globally Harmonised System of Classification and Labelling of Chemicals (hereinafter ‘GHS’) of the United Nations has brought about changes which were not fully taken into account in Commission Regulation (EU) No 487/2013 (2). For reasons of consistency it is necessary to provide for full alignment between the GHS and Regulation (EC) No 1272/2008.
(2)
Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (3). Those two lists need to be amended to include updated classifications for substances already subject to those harmonised classifications and to include new harmonised classifications.
(3)
The Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA) has issued opinions on proposals for harmonised classification and labelling of substances which had been submitted to ECHA pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on those opinions, as well as on the comments received from the parties concerned, it is appropriate to amend Annex VI to Regulation (EC) No 1272/2008 in order to harmonise the classification and labelling of certain substances.
(4)
The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow operators to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (4).
(5)
With regard to the substance pitch, coal tar, high-temp. (EC Number: 266-028-2), an extended period of time will be necessary to allow operators to comply with the obligations resulting from the new harmonised classification for substances classified as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 3 and Annex III of Directive 2008/68/EC of the European Parliament and of the Council of 24 September 2008 on the inland transport of dangerous goods (5). Therefore, a longer transition time should be foreseen before the harmonised classification has to be applied.
(6)
With regard to the substance gallium arsenide (EC Number: 215-114-8), the RAC is in the process of adopting a new opinion for the hazard class ‘toxicity to reproduction’. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until that opinion is finalised.
(7)
With regard to the substance polyhexamethylene biguanide hydrochloride (CAS number 27083-27-8 or 32289-58-0), new scientific data has been made available for the hazard class ‘acute toxicity (inhalation)’, which suggests that the classification for this hazard class as recommended in the RAC opinion, which is based on older data, might not be appropriate. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until RAC has had the opportunity to deliver an opinion on the new information, while all other hazard classes covered by the earlier RAC opinion should be included.
(8)
In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly on a voluntary basis before the dates by which the harmonised classifications will become mandatory.
(9)
The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,
HAS ADOPTED THIS REGULATION:
Article 1
Regulation (EC) No 1272/2008 is amended as follows:
(1)
Annex IV is amended in accordance with the Annex I to this Regulation;
(2)
Part 3 of Annex VI is amended as follows:
(a)
Table 3.1 is amended as follows:
(i)
The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex II to this Regulation are replaced by the entries set out in Annex II to this Regulation;
(ii)
The entries set out in Annex III to this Regulation are inserted in accordance with the order of the entries set out in Table 3.1.
(b)
Table 3.2 is amended as follows:
(i)
The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex IV to this Regulation are replaced by the entries set out in in Annex IV to this Regulation;
(ii)
The entries set out in Annex V to this Regulation are inserted in accordance with the order of the entries set out in Table 3.2.
Article 2
1. By way of derogation from Article 3(2) substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation.
2. By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 December 2016.
3. By way of derogation from Article 3(2) mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Council (6) or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 June 2017.
4. By way of derogation from Article 3(3) the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, may be applied before the dates referred to in Article 3(3).
Article 3
1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
2. Article 1(1) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.
3. Article 1(2) shall apply from 1 January 2015 for all entries except for the entry pitch, coal tar, high-temp. (EC Number 266-028-2), for which Article 1 shall apply from 1 April 2016.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 2 October 2013.
For the Commission
The President
José Manuel BARROSO
(1) OJ L 353, 31.12.2008, p. 1.
(2) OJ L 149, 1.6.2013, p. 1.
(3) OJ 196, 16.8.1967, p. 1.
(4) OJ L 396, 30.12.2006, p. 1.
(5) OJ L 260, 30.9.2008, p. 13.
(6) OJ L 200, 30.7.1999, p. 1.
ANNEX I
In Part 1, Table 6.2 of Annex IV to Regulation (EC) No 1272/2008, Code P210 is replaced by the following:
‘P210
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5
Flammable gases (section 2.2)
1, 2
Aerosols (section 2.3)
1, 2, 3
Flammable liquids (section 2.6)
1, 2, 3
Flammable solids (section 2.7)
1, 2
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)
1
Pyrophoric solids (section 2.10)
1
Oxidising liquids (section 2.13)
1, 2, 3
Oxidising solids (section 2.14)
1, 2, 3
Organic peroxides (section 2.15)
Types A, B, C, D, E, F’
ANNEX II
Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Specific Conc. Limits,
M — Factors
Notes
Hazard Class and Category Code(s)
Hazard statement Code(s)
Pictogram, Signal Word Code(s)
Hazard statement Code(s)
Suppl. Hazard statement Code(s)
015-004-00-8
aluminium phosphide
244-088-0
20859-73-8
Water-react. 1
H260
GHS02
H260
EUH029
M = 100
Acute Tox. 2
H300
GHS06
H300
EUH032
Acute Tox. 3
H311
GHS09
H311
Acute Tox. 1
H330
Dgr
H330
Aquatic Acute 1
H400
H400
015-005-00-3
magnesium phosphide;
trimagnesium diphosphide
235-023-7
12057-74-8
Water-react. 1
H260
GHS02
H260
EUH029
M = 100
Acute Tox. 2
H300
GHS06
H300
EUH032
Acute Tox. 3
H311
GHS09
H311
Acute Tox. 1
H330
Dgr
H330
Aquatic Acute 1
H400
H400
015-123-00-5
fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-1
22224-92-6
Acute Tox. 2
H300
GHS06
H300
M = 100
M = 100
Acute Tox. 2
H310
GHS09
H310
Acute Tox. 2
H330
Dgr
H330
Eye Irrit. 2
H319
H319
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
030-012-00-1
aluminium-magnesium-zinc-carbonate-hydroxide
423-570-6
169314-88-9
Aquatic Chronic 4
H413
H413
602-006-00-4
chloroform;
trichloromethane
200-663-8
67-66-3
Carc. 2
H351
GHS06
H351
Repr. 2
H361d
GHS08
H361d
Acute Tox. 3
H331
Dgr
H331
Acute Tox. 4
H302
H302
STOT RE 1
H372
H372
Eye Irrit. 2
H319
H319
Skin Irrit. 2
H315
H315
603-097-00-3
1,1’,1’-nitrilotripropan-2-ol;
triisopropanolamine
204-528-4
122-20-3
Eye Irrit. 2
H319
GHS07
Wng
H319
605-008-00-3
acrolein;
prop-2-enal;
acrylaldehyde
203-453-4
107-02-8
Flam. Liq. 2
H225
GHS02
H225
EUH071
Skin Corr. 1; H314: C ≥ 0,1 %
D
Acute Tox. 1
H330
GHS06
H330
Acute Tox. 2
H300
GHS05
H300
Acute Tox. 3
H311
GHS09
H311
Skin Corr. 1
H314
Dgr
H314
Aquatic Acute 1
H400
M = 100
Aquatic Chronic 1
H410
H410
M = 1
607-023-00-0
vinyl acetate
203-545-4
108-05-4
Flam. Liq. 2
H225
GHS02
H225
D
Carc. 2
H351
GHS08
H351
Acute Tox. 4
H332
GHS07
H332
STOT SE 3
H335
Dgr
H335
607-613-00-8
reaction mass of:
succinic acid
monopersuccinic acid
dipersuccinic acid
monomethyl ester of succinic acid
monomethyl ester of persuccinic acid
dimethyl succinate glutaric acid
monoperglutaric acid
diperglutaric acid
monomethyl ester of glutaric acid
monomethyl ester of perglutaric acid
dimethyl glutarate adipic acid
monoperadipic acid
diperadipic acid
monomethyl ester of adipic acid
monomethyl ester of peradipic acid
dimethyl adipate
hydrogen peroxide
methanol
water
432-790-1
Acute Tox. 4*
H332
GHS07
H332
Acute Tox. 4*
H312
GHS05
H312
Acute Tox. 4*
H302
GHS08
H302
Skin Corr. 1B
H314
Dgr
H314
STOT SE 2
H371 (eyes)
H371 (eyes)
609-003-00-7
nitrobenzene
202-716-0
98-95-3
Carc. 2.
H351
GHS06
H351
Repr. 1B
H360F
GHS08
H360F
Acute Tox. 3
H301
Dgr
H301
Acute Tox. 3
H331
H331
Acute Tox. 3
H311
H311
STOT RE 1
H372 (blood)
H372 (blood)
Aquatic Chronic 3
H412
H412
612-120-00-6
aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline
277-704-1
74070-46-5
Carc. 2
H351
GHS08
H351
M = 100
M = 10
Skin Sens. 1A
H317
GHS07
H317
Aquatic Acute 1
H400
GHS09
Aquatic Chronic 1
H410
Wng
H410
613-175-00-9
epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane
406-850-2
133855-98-8
Carc. 2
H351
GHS08
H351
Repr. 1B
H360Df
GHS09
H360Df
Aquatic Chronic 2
H411
Dgr
H411
616-200-00-1
reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)
432-430-3
Aquatic Chronic 4
H413
H413
648-055-00-5
pitch, coal tar, high-temp.;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
266-028-2
65996-93-2
Carc. 1A
H350
GHS08
H350
M = 1000
M = 1000
Muta. 1B
H340
GHS09
H340
Repr. 1B
H360FD
Dgr
H360FD
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
649-330-00-2
naphtha (petroleum), hydrodesulphurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-185-4
64742-82-1
Carc. 1B
H350
GHS08
H350
P
Muta. 1B
H340
Dgr
H340
STOT RE 1
H372 (central nervous system)
H372 (central nervous system)
Asp. Tox. 1
H304
H304
649-345-00-4
stoddard solvent;
Low boiling point naphtha — unspecified;
[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]
232-489-3
8052-41-3
Carc. 1B
H350
GHS08
H350
P
Muta. 1B
H340
Dgr
H340
STOT RE 1
H372 (central nervous system)
H372 (central nervous system)
Asp. Tox. 1
H304
H304
649-405-00-X
solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]
265-191-7
64742-88-7
STOT RE 1
H372 (central nervous system)
GHS08
H372 (central nervous system)
Asp. Tox. 1
H304
Dgr
H304
ANNEX III
Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Specific Conc. Limits,
M — Factors
Notes
Hazard Class and Category Code(s)
Hazard statement Code(s)
Pictogram, Signal Word Code(s)
Hazard statement Code(s)
Suppl. Hazard statement Code(s)
031-001-00-4
gallium arsenide
215-114-8
1303-00-0
Carc. 1B
H350
GHS08
H350
STOT RE 1
H372 (respiratory and haematopoietic systems)
Dgr
H372 (respiratory and haematopoietic systems)
050-025-00-6
trichloromethylstannane
213-608-8
993-16-8
Repr. 2
H361d
GHS08
Wng
H361d
050-026-00-1
2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
260-828-5
57583-34-3
Repr. 2
H361d
GHS08
Wng
H361d
050-027-00-7
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
239-622-4
15571-58-1
Repr. 1B
H360D
GHS08
Dgr
H360D
601-087-00-3
2,4,4-trimethylpentene
246-690-9
25167-70-8
Flam. Liq. 2
H225
GHS02
H225
D
Asp. Tox. 1
H304
GHS07
H304
STOT SE 3
H336
GHS08
Dgr
H336
606-145-00-1
sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione
99105-77-8
Repr. 2
H361d
GHS08
H361d
M = 1
M = 10
STOT RE 2
H373 (kidneys)
GHS07
H373 (kidneys)
Skin Sens. 1A
H317
GHS09
H317
Aquatic Acute 1
H400
Wng
Aquatic Chronic 1
H410
H410
607-699-00-7
bifenthrin (ISO);
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
82657-04-3
Carc. 2
H351
GHS06
H351
M = 10 000
M = 100 000
Acute Tox. 3
H331
GHS08
H331
Acute Tox. 2
H300
GHS09
H300
STOT RE 1
H372 (nervous system)
Dgr
H372 (nervous system)
Skin Sens. 1B
H317
H317
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
607-700-00-0
indoxacarb (ISO);
methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]
173584-44-6 [1]
Acute Tox. 3
H301
GHS06
H301
M = 1
M = 1
Acute Tox. 4
H332
GHS08
H332
STOT RE 1
H372 (blood, nervous system, heart)
GHS09
H372 (blood, nervous system, heart)
Skin Sens. 1B
H317
Dgr
H317
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]
144171-61-9 [2]
607-702-00-1
dihexyl phthalate
201-559-5
84-75-3
Repr. 1B
H360FD
GHS08
Dgr
H360FD
607-703-00-7
ammoniumpentadeca- fluorooctanoate
223-320-4
3825-26-1
Carc. 2
H351
GHS08
H351
Repr. 1B
H360D
GHS07
H360D
Lact.
H362
GHS05
H362
Acute Tox. 4
H332
Dgr
H332
Acute Tox. 4
H302
H302
STOT RE 1
H372 (liver)
H372 (liver)
Eye Dam.1
H318
H318
607-704-00-2
perfluorooctanoic acid
206-397-9
335-67-1
Carc. 2
H351
GHS08
H351
Repr. 1B
H360D
GHS07
H360D
Lact.
H362
GHS05
H362
Acute Tox. 4
H332
Dgr
H332
Acute Tox. 4
H302
H302
STOT RE 1
H372 (liver)
H372 (liver)
Eye Dam. 1
H318
H318
612-282-00-8
octadecylamine
204-695-3
124-30-1
Asp. Tox. 1
H304
GHS05
H304
M = 10
M = 10
STOT RE 2
H373 (gastro-intestinal tract, liver, immune system)
GHS08
H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2
H315
GHS09
H315
Eye Dam. 1
H318
Dgr
H318
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
612-283-00-3
(Z)-octadec-9-enylamine
204-015-5
112-90-3
Acute Tox. 4
H302
GHS05
H302
M = 10
M = 10
Asp Tox. 1
H304
GHS07
H304
STOT SE 3
H335
GHS08
H335
STOT RE 2
H373 (gastro-intestinal tract, liver, immune system)
GHS09
H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1B
H314
Dgr
H314
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
612-284-00-9
amines, hydrogenated tallow alkyl
262-976-6
61788-45-2
Asp Tox. 1
H304
GHS08
H304
M = 10
M = 10
STOT RE 2
H373 (gastro-intestinal tract, liver, immune system)
GHS05
H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2
H315
GHS09
H315
Eye Dam. 1
H318
Dgr
H318
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
612-285-00-4
amines, coco alkyl
262-977-1
61788-46-3
Acute Tox. 4
H302
GHS05
H302
M = 10
M = 10
Asp. Tox. 1
H304
GHS07
H304
STOT SE 3
H335
GHS08
H335
STOT RE 2
H373 (gastro-intestinal tract, liver, immune system)
GHS09
H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1B
H314
Dgr
H314
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
612-286-00-X
amines, tallow alkyl
263-125-1
61790-33-8
Acute Tox. 4
H302
GHS05
H302
M = 10
M = 10
Asp. Tox. 1
H304
GHS07
H304
STOT RE 2
H373 (gastro-intestinal tract, liver, immune system)
GHS08
H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1B
H314
GHS09
H314
Aquatic Acute 1
H400
Dgr
Aquatic Chronic 1
H410
H410
616-206-00-4
flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea
417-680-3
101463-69-8
Lact.
H362
GHS09
H362
M = 10 000
M = 10 000
Aquatic Acute 1
H400
Wng
Aquatic Chronic 1
H410
H410
616-207-00-X
polyhexamethylene biguanide hydrochloride
27083-27-8 or 32289-58-0
Carc. 2
H351
GHS05
H351
M = 10
M = 10
Acute Tox. 4
H302
GHS07
H302
STOT RE 1
H372 (respiratory tract) (inhalation)
GHS08
H372 (respiratory tract) (inhalation)
Eye Dam. 1
H318
GHS09
H318
Skin Sens. 1B
H317
Dgr
H317
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
616-208-00-5
N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one
220-250-6
2687-91-4
Repr. 1B
H360D
GHS08
Dgr
H360D
616-209-00-0
amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea
407-380-0
120923-37-7
Aquatic Acute 1
H400
GHS09
M = 100
M = 100
Aquatic Chronic 1
H410
Wng
H410
616-210-00-6
tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide
119168-77-3
Acute Tox. 3
H301
GHS06
H301
M = 10
M = 10
Acute Tox. 4
H332
GHS08
H332
STOT RE 2
H373 (gastro-intestinal tract) (Oral)
GHS09
H373 (gastro-intestinal tract) (Oral)
Skin Sens. 1B
H317
Dgr
H317
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
H410
616-211-00-1
proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one
189278-12-4
Carc. 2
H351
GHS08
H351
M = 1
M = 10
Aquatic Acute 1
H400
GHS09
Aquatic Chronic 1
H410
Wng
H410
ANNEX IV
Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Concentration Limits
Notes
015-004-00-8
aluminium phosphide
244-088-0
20859-73-8
F; R15/29
T+; R26/28
Xn; R21
R32
N; R50
F; T+; N
R: 15/29-21-26/28-32-50
S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61
N; R50: C ≥ 0,25 %
015-005-00-3
magnesium phosphide;
trimagnesium diphosphide
235-023-7
12057-74-8
F; R15/29
T+; R26/28
Xn; R21
R32
N; R50
F; T+; N
R: 15/29-21-26/28-32-50
S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61
N; R50: C ≥ 0,25 %
015-123-00-5
fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-1
22224-92-6
T+; R26/28
T; R24
Xi; R36
N; R50-53
T+; N
R: 24-26/28-36-50/53
S: (1/2-)23-26-28-35-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %
030-012-00-1
aluminium-magnesium-zinc-carbonate-hydroxide
423-570-6
169314-88-9
R53
R: 53
S: 61
602-006-00-4
chloroform;
trichloromethane
200-663-8
67-66-3
Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R20/22-48/20
Xi; R36/38
Xn
R: 20/22-36/38-40-48/20-63
S: (2-)36/37
603-097-00-3
1,1′,1′′-nitrilotripropan-2-ol;
triisopropanolamine
204-528-4
122-20-3
Xi; R36
Xi
R: 36
S: (2-)26
605-008-00-3
acrolein;
prop-2-enal;
acrylaldehyde
203-453-4
107-02-8
F; R11
T+; R26/28
T; R24
C; R34
N; R50
F; T+; N
R: 11-24-26/28-34-50
S: (1/2-)23-26-28-36/37/39-45-61
C; R34: C ≥ 0,1 %
N; R50: C ≥ 0,25 %
D
607-023-00-0
vinyl acetate
203-545-4
108-05-4
F; R11
Carc. Cat. 3; R40
Xn; R20
Xi; R37
F; Xn
R: 11-20-37-40
S: 9-16-33-36/37
D
607-613-00-8
reaction mass of:
succinic acid
monopersuccinic acid
dipersuccinic acid
monomethyl ester of succinic acid
monomethyl ester of persuccinic acid
dimethyl succinate
glutaric acid
monoperglutaric acid
diperglutaric acid
monomethyl ester of glutaric acid
monomethyl ester of perglutaric acid
dimethyl glutarate
adipic acid
monoperadipic acid
diperadipic acid
monomethyl ester of adipic acid
monomethyl ester of peradipic acid
dimethyl adipate
hydrogen peroxide
methanol
water
432-790-1
C; R34
Xn; R20/21/22-68/20/21/22
C
R: 20/21/22-34-68/20/21/22
S: (1/2-)26-28-36/37/39-45
609-003-00-7
nitrobenzene
202-716-0
98-95-3
Carc. Cat. 3; R40
Repr. Cat. 2; R60
T; R23/24/25-48/23/24/25
R52-53
T
R: 23/24/25-48/23/24/25-40-60-52/53
S: 45-53
612-120-00-6
aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline
277-704-1
74070-46-5
Carc. Cat. 3; R40
R43
N; R50-53
Xn; N
R: 40-43-50/53
S: (2-)36/37-60-61
R43: C ≥ 0,1 %
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %
613-175-00-9
epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
406-850-2
133855-98-8
Carc. Cat. 3; R40
Repr. Cat. 2; R61
Repr. Cat. 3; R62
N; R51-53
T; N
R: 61-40-62-51/53
S: 45-53-61
616-200-00-1
reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)
432-430-3
R53
R: 53
S: 61
648-055-00-5
pitch, coal tar, high-temp.;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
266-028-2
65996-93-2
Carc. Cat. 1; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
N; R50-53
T; N
R: 45-46-60-61-50/53
S: 45-53-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C <
0,025 %
R52-53: 0,00025 % ≤ C <
0,0025 %
649-330-00-2
naphtha (petroleum), hydrodesulphurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-185-4
64742-82-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/20-65
T
R: 45-46-48/20-65
S: 45-53
P
649-345-00-4
stoddard solvent;
Low boiling point naphtha — unspecified;
[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]
232-489-3
8052-41-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/20-65
T
R: 45-46-48/20-65
S: 45-53
P
649-405-00-X
solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]
265-191-7
64742-88-7
Xn; R48/20-65
Xn
R: 48/20-65
S: (2-)23-24-62
ANNEX V
Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Concentration Limits
Notes
031-001-00-4
gallium arsenide
215-114-8
1303-00-0
Carc. Cat. 2; R45
T; R48/23
T
R: 45-48/23
S: 45-53
E
050-025-00-6
trichloromethylstannane
213-608-8
993-16-8
Repr. Cat. 3; R63
Xn
R: 63
S: (2-)22-36/37
050-026-00-1
2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
260-828-5
57583-34-3
Repr. Cat. 3; R63
Xn
R: 63
S: (2-)22-36/37
050-027-00-7
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
239-622-4
15571-58-1
Repr. Cat. 2; R61
T
R: 61
S: 45-53
601-087-00-3
2,4,4-trimethylpentene
246-690-9
25167-70-8
F; R11
Xn; R65
R67
F; Xn
R: 11-65-67
S: 9-16-33-62
D
606-145-00-1
sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione
99105-77-8
Repr. Cat. 3; R63
Xn; R48/22
R43
N; R50-53
Xn; N
R: 43-48/22-63-50/53
S: (2-)22-36/37-60-61
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C< 2,5 %
R43: C ≥ 0,1 %
607-699-00-7
bifenthrin (ISO);
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
82657-04-3
Carc. Cat 3; R40
T; R23/25
Xn; R48/22
R43
N; R50-53
T; N
R: 23/25-40-43-48/22-50/53
S: (1/2-)23-24-36/37-38- 45-60-61
N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C< 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 %
607-700-00-0
indoxacarb (ISO);
methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate
173584-44-6
T; R25-48/25
Xn; R20
R43
N; R50-53
T; N
R: 20-25-43-48/25-50/53
S: (1/2-)24-37-45-60-61
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
607-701-00-6
reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate
144171-61-9
T; R48/25
Xn; R20/22
R43
N; R50-53
T; N
R: 20/22-43-48/25-50/53
S: (1/2-)24-37-45-60-61
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
607-702-00-1
dihexyl phthalate
201-559-5
84-75-3
Repr. Cat. 2; R60-61
T
R: 60-61
S: 45-53
607-703-00-7
ammoniumpentade-cafluorooctanoate
223-320-4
3825-26-1
Carc. Cat. 3; R40
Repr. Cat. 2; R61
R64
T; R48/23
Xn; R20/22-48/21/22
Xi; R41
T
R: 61-20/22-40-41- 48/23-48/21/22-64
S: 45-53
607-704-00-2
perfluorooctanoic acid
206-397-9
335-67-1
Carc. Cat. 3; R40
Repr. Cat. 2; R61
R64
T; R48/23
Xn; R20/22-48/21/22
Xi; R41
T
R: 61-20/22-40-41-48/23-48/21/22-64
S: 45-53
612-282-00-8
octadecylamine
204-695-3
124-30-1
Xn; R48/22-65
Xi; R38-41
N; R50-53
Xn; N
R: 38-41-48/22-65-50/53
S: (2-)26-36/37/39-60-61-62
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
612-283-00-3
(Z)-octadec-9-enylamine
204-015-5
112-90-3
Xn; R22-48/22-65
C; R34
N; R50-53
C; N
R: 22-34-48/22-65-50/53
S: (1/2-)23-26-36/37/39-45-60-61-62
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
612-284-00-9
amines, hydrogenated tallow alkyl
262-976-6
61788-45-2
Xn; R48/22-65
Xi; R38-41
N; R50-53
Xn; N
R: 38-41-48/22-65-50/53
S: (2-)26-36/37/39-60-61-62
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
612-285-00-4
amines, coco alkyl
262-977-1
61788-46-3
Xn; R22-48/22-65
C; R35
N; R50-53
C; N
R: 22-35-48/22-65-50/53
S: (1/2-)23-26-36/37/39-45-60-61-62
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
612-286-00-X
amines, tallow alkyl
263-125-1
61790-33-8
Xn; R22-48/22-65
C; R35
N; 50-53
C; N
R: 22-35-48/22-65-50/53
S: (1/2-)26-36/37/39-45-60-61-62
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
616-206-00-4
flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea
417-680-3
101463-69-8
R64
R33
N; R50-53
N
R: 33-64-50/53
S: (2-)22-36/37-46-60-61
N; R50-53 C ≥ 0,0025 %
N; R51-53 0,00025 % ≤ C < 0,0025 %
R52-53 0,000025 % ≤ C < 0,00025 %
616-207-00-X
polyhexamethylene biguanide hydrochloride
27083-27-8 or 32289-58-0
Carc. Cat 3; R40
Xn; R22
T; R48/23
Xi; R41
R43
N; R50-53
T; N
R: 22-40-41-43-48/23-50/53
S: (1/2-)22-36/37/39-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
616-208-00-5
N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one
220-250-6
2687-91-4
Repr. Cat. 2; R61
T
R: 61
S: 45-53
616-209-00-0
amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea
407-380-0
120923-37-7
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %
616-210-00-6
tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5-carboxamide
119168-77-3
Xn; R20/22
R43
N; R50-53
Xn; N
R: 20/22-43-50/53
S: (2-)24-37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
616-211-00-1
proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one
189278-12-4
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61